Enliven Therapeutics, Inc. (ELVN)
46.97
+0.76
(+1.64%)
USD |
NASDAQ |
Oct 02, 16:00
46.97
0.00 (0.00%)
After-Hours: 20:00
Enliven Therapeutics Price : 46.97 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 47.38 | 47.43 | 45.92 | 46.97 | 1.123M |
| Oct 01, 2026 | 46.29 | 47.22 | 45.70 | 46.21 | 944890.0 |
| Sep 30, 2026 | 46.98 | 46.98 | 45.47 | 45.84 | 800171.0 |
| Sep 29, 2026 | 46.01 | 46.87 | 45.40 | 46.51 | 1.256M |
| Sep 28, 2026 | 44.38 | 46.90 | 44.19 | 46.01 | 1.285M |
| Sep 25, 2026 | 45.54 | 45.77 | 44.18 | 44.75 | 963790.0 |
| Sep 24, 2026 | 45.90 | 46.52 | 44.81 | 45.17 | 749360.0 |
| Sep 23, 2026 | 47.84 | 48.03 | 45.66 | 46.09 | 1.551M |
| Sep 22, 2026 | 49.07 | 49.13 | 47.70 | 48.19 | 1.213M |
| Sep 21, 2026 | 49.45 | 49.52 | 47.98 | 48.87 | 2.281M |
| Sep 18, 2026 | 50.15 | 51.20 | 49.19 | 49.45 | 6.006M |
| Sep 17, 2026 | 49.58 | 51.83 | 49.32 | 50.24 | 1.963M |
| Sep 16, 2026 | 53.70 | 54.12 | 48.42 | 49.12 | 2.915M |
| Sep 15, 2026 | 54.32 | 54.50 | 52.98 | 53.36 | 866959.0 |
| Sep 14, 2026 | 55.00 | 55.83 | 54.00 | 54.43 | 858164.0 |
| Sep 11, 2026 | 57.00 | 57.00 | 54.12 | 54.32 | 995816.0 |
| Sep 10, 2026 | 57.15 | 57.82 | 56.05 | 56.23 | 769641.0 |
| Sep 09, 2026 | 59.05 | 59.96 | 57.29 | 57.45 | 1.294M |
| Sep 08, 2026 | 58.75 | 59.90 | 58.24 | 59.37 | 1.326M |
| Sep 04, 2026 | 59.69 | 59.89 | 58.96 | 59.32 | 1.113M |
| Sep 03, 2026 | 58.88 | 60.10 | 58.66 | 59.65 | 806070.0 |
| Sep 02, 2026 | 58.36 | 60.55 | 57.36 | 59.01 | 609969.0 |
| Sep 01, 2026 | 57.99 | 58.45 | 57.23 | 57.86 | 1.056M |
| Aug 31, 2026 | 57.50 | 58.78 | 56.33 | 57.89 | 982051.0 |
| Aug 28, 2026 | 60.40 | 61.18 | 57.73 | 57.86 | 584982.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Definium Therapeutics, Inc. | 37.40 |
| Cocrystal Pharma, Inc. | 1.145 |
| CNBX Pharmaceuticals, Inc. | 0.0001 |
| Arvinas, Inc. | 7.41 |
| Fulcrum Therapeutics, Inc. | 3.69 |
Price Related Metrics
| Price to Book Value | 3.844 |
| Earnings Yield | -3.55% |
| Market Cap | 3.441B |